-
March 12, 2012
Today India has granted its first compulsory licence over a drug. But what of other countries that have used the IP system to make it easier for patients to access medicines?
-
March 12, 2012
In one of his final tasks before leaving the job, the outgoing head of India’s patent office has issued the country’s first compulsory licence over a drug since India began protecting pharmaceutical products seven years ago
-
March 12, 2012
India’s Controller of Patents has issued a compulsory licence over a cancer-treating drug, sorafenib, whose patent is held by Bayer
-
February 13, 2012
The latest round of negotations between the EU and India over a free-trade agreement was disrupted by protests over the way the IP clauses in the deal could affect access to medicines in developing countries
-
September 22, 2011
Indian generic drug maker Natco has filed a compulsory licence application for the patent covering German pharma company Bayer’s anti-cancer drug Nexavar
-
June 20, 2011
P H Kurian, the reforming head of India’s IP office, has resigned after completing less than half of his five-year term
-
June 14, 2011
A government consultation paper on introducing a system of utility model patents in India has been welcomed by patent practitioners, who believe it will help to stimulate domestic innovation
-
May 03, 2011
The dispute between German wind turbine maker Enercon and its Indian subsidiary has shown that a little known part of India’s Patent Act could have a devastating effect on foreign patent owners
-
May 03, 2011
A German company has had 12 patents revoked by its own Indian subsidiary and lost control of its trade mark in a dispute that has raised more questions about India’s IP system
-
April 07, 2011
The final version of India’s long-awaited Patent Manual has failed to clarify some of the grey areas in the country’s patent system
-
February 11, 2011
A Court in Chennai has agreed to hear a petition challenging the constitutionality of the tribunal that hears India’s patent and trade mark appeals
-
November 01, 2010
Gladys Mirandah and David Reed of Patrick Mirandah Co (pmc) discuss third party opposition and invalidation
-
November 15, 2010
Practitioners in India have praised the latest draft patent manual for examiners but called for more clarity over software and pharmaceutical patents
-
September 01, 2010
Greg Kalbaugh tells Peter Ollier about the work the US-India Business Council does to promote IP rights in India
-
August 22, 2008
A draft of India’s new manual for patent examiners is causing controversy because of clauses dealing with the patentability of new drugs and software programs
-
September 01, 2010
Thanks to recent patent reforms and its pending membership of the Madrid Protocol, India is firmly part of the global IP system. But, as DIPP joint secretary V Bhaskar tells James Nurton, the country remains sceptical of further harmonisation as it seeks to balance IP protection and development
-
August 31, 2009
Swiss drug maker Novartis has asked India’s Supreme Court to review the patentability of its anti-cancer blockbuster, Glivec